are glp 1 drugs dangerous America's Poison Centers Obesity drugs: huge study identifies
Description
10.1136/bmj.q1645 [DOI] [PubMed] [Google Scholar] 10.Gulak MA, Murphy P
In addition to their glycemic effects, DPP-4 inhibitors have the potential to decrease bone resorption, increase bone formation, and reduce the incidence of osteoporosis and fractures
All-cause mortality was reported in 8 of the 11 studies
Survodutide may directly reduce both
Diabetes Obes Metab 21(6):14981501 Vinciguerra F et al (2024) Efficacy of high-dose Liraglutide 3.0 mg in patients with poor response to bariatric surgery: real-world experience and updated meta-analysis
Thyroid cancer is a different story: a boxed warning exists because of rodent studies, and human data are inconclusive
